Home › Samsung and Alcedis Collaboration Enhances Wearable Health Data Quality

Samsung and Alcedis Collaboration Enhances Wearable Health Data Quality

6/25/2026
Samsung and Alcedis Collaboration Enhances Wearable Health Data Quality

Samsung and Alcedis: Collaboration for Better Health Data

Samsung, one of the world's technology giants, recently announced a strategic partnership with Alcedis, a digital clinical research company. This collaboration aims to combine health data generated by wearable devices with clinical research. Through this initiative, Samsung is committed to providing valuable health data produced by its devices, while Alcedis will play a role in collecting, analyzing, and translating biometric data into meaningful evidence for pharmaceutical and clinical research.

The Important Role of Wearable Devices in Health

In recent years, wearable devices have become increasingly popular among the public. With the ability to monitor various health aspects in real-time, these devices offer an effective and economical way to collect health data from a broader population. However, challenges arise when translating the collected data into reliable clinical evidence. This is where Alcedis's role becomes crucial.

  • Clinical Validation Data Collection
  • Bioelectrical Impedance Analysis (BIA) Analysis
  • Electrodermal Activity (EDA) Measurement
  • Monitoring of Sleep Disorders and Atrial Fibrillation

Transforming Data into Clinical Evidence

This collaboration will not only generate data but also process it into information usable in clinical research. Alcedis will collect clinically validated measurements, such as bioelectrical impedance analysis (BIA) and electrodermal activity (EDA). Additionally, the wearable devices used are capable of gathering data related to obstructive sleep apnea (OSA) and atrial fibrillation (AFib), serious health conditions that require medical attention.

Opportunities and Challenges Ahead

With more people using wearable devices, the opportunity to collect continuous and relevant health data grows. However, the main challenge remains: how to translate this data into evidence that can be used in drug development and clinical research? The partnership between Samsung and Alcedis is expected to address this challenge and make a significant contribution to advancing health science.

Hope for the Future of Digital Health

This collaboration represents a step forward in integrating technology and health. With Samsung providing data from wearable devices and Alcedis translating that data into valid evidence, progress is expected in developing more effective therapies and medications. Although there is skepticism about data collection by large companies, initiatives like this can serve as a bridge to better understanding human health and developing improved solutions for existing diseases.

Source: https://www.gsmarena.com/samsung_partners_with_a_clinical_research_firm_and_will_provide_health_data_from_its_wearable_device-news-73432.php

Also Read

Advertisement